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Abstract. 
 
The proapoptotic protein BAX contains a 
single predicted transmembrane domain at its COOH 
terminus. In unstimulated cells, BAX is located in the 
cytosol and in peripheral association with intracellular 
membranes including mitochondria, but inserts into mi-
tochondrial membranes after a death signal. This fail-
ure to insert into mitochondrial membrane in the ab-
sence of a death signal correlates with repression of the 
transmembrane signal-anchor function of BAX by the 
NH
 
2
 
-terminal domain. Targeting can be instated by de-
leting the domain or by replacing the BAX transmem-
brane segment with that of BCL-2. In stimulated cells, 
the contribution of the NH
 
2
 
 terminus of BAX corre-
lates with further exposure of this domain after mem-
brane insertion of the protein. The peptidyl caspase
inhibitor zVAD-fmk partly blocks the stimulated mito-
chondrial membrane insertion of BAX in vivo, which is 
consistent with the ability of apoptotic cell extracts to 
support mitochondrial targeting of BAX in vitro, de-
pendent on activation of caspase(s). Taken together, 
our results suggest that regulated targeting of BAX to 
mitochondria in response to a death signal is mediated 
by discrete domains within the BAX polypeptide. The 
contribution of one or more caspases may reflect an ini-
tiation and/or amplification of this regulated targeting.
Key words: apoptosis • BAX • cytochrome c • 
caspase • mitochondria
 
T
 
he 
 
response of metazoan cells to apoptotic death
signals depends on the status of various regulatory
checkpoints in the cell. Prominent among these is
the BCL-2 family of proteins whose members include
dominant suppressors (Ced-9, BCL-2, BCL-X
 
L
 
, BCL-w,
A1, MCL-1) and proapopototic inducers (BAX, BAK,
BCL-X
 
s
 
) of cell death, as well as proapoptotic inhibitors of
BCL-2/BCL-X
 
L
 
 function (BAD, BID; Yang and Kors-
meyer, 1996). The relationships among these family mem-
bers are complex, and in the case of the BCL-2 suppressor
and BAX inducer, are further complicated by their appar-
ent ability to function autonomously in regulating cell
death (Cheng et al., 1996; Knudson and Korsmeyer, 1997),
while at the same time influencing one another’s activities
via heterodimeric interactions (Oltvai et al., 1993). BCL-2
suppressors function upstream of caspase death effectors
such as caspase-3 to inhibit cell death (Boulakia et al.,
1996; Chinnaiyan et al., 1996; Armstrong et al., 1996),
which is likely accomplished in several ways. These in-
clude recruitment and regulation of Ced-4 like molecules
(Shaham and Horvitz, 1996; Wu et al., 1997; Chinnaiyan et
al., 1997; Spector et al., 1997; James et al., 1997) and Ced-4
like adaptors (Chinnaiyan et al., 1997; Ng and Shore, 1998)
that are required for activation of initiator caspases and
recruitment of kinases (Wang et al., 1996) and phos-
phatases (Shibasaki et al., 1997) that may regulate the
activity of BCL-2-associated complexes. Moreover, regu-
lation of BCL-2 complexes may influence formation of
ion-conducting pores (Minn et al., 1997; Schendel et al.,
1997; Schlesinger et al., 1997) or the channel activities of
membranes in which BCL-2 resides. While BAX may af-
fect all of these BCL-2–mediated events via heterodimeric
modulation, BAX is also capable of autonomous pore for-
mation in lipid bilayers (Schlesinger et al., 1997; Antonn-
son et al., 1997). The ability of elevated levels of BAX or
BAK to initiate cell death in the absence of any additional
signal in vivo (Xiang et al., 1996; McCarthy et al., 1997;
Rossé et al., 1998) correlates with severe intracellular
membrane dysfunction that includes redistribution of mi-
tochondrial cytochrome c to the cytosol and induced mito-
chondria permeability transition.
Most BCL-2 and BAX family proteins contain at their
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extreme COOH terminus a single predicted transmem-
brane segment (TM)
 
1
 
. In the case of BCL-2, the TM func-
tions as a signal anchor that targets and inserts the protein
in a N
 
cyto
 
-C
 
in
 
 orientation into the two main membrane lo-
cations for this protein: the mitochondrial outer mem-
brane and the ER/nuclear envelope (Hockenbery et al.,
1990; Krajewski et al., 1993; Nguyen et al., 1993; Nguyen et
al., 1994). Strikingly, however, the ability of BAX to trans-
locate to membrane sites, including mitochondria, is regu-
lated in certain contexts and depends upon the cell receiv-
ing a death signal (Hsu et al., 1997; Wolter et al., 1997). In
the absence of such a signal, BAX is found free in the cy-
tosol or peripherally associated with endocellular mem-
brane surfaces. Although the mechanism for regulated tar-
geting of BAX or BAK remains to be elucidated, the fact
that transient overexpression (Xiang et al., 1996; Rossé et
al., 1998) or forced dimerization (Gross et al., 1998) of the
protein can lead to cell death in the absence of other sig-
nals implies that the regulatory mechanism can be overrid-
den in certain contexts.
Here we demonstrate that BAX targeting to mitochon-
dria can be regulated by zVAD-sensitive caspase(s). Sig-
nificantly, prevention of BAX targeting in the absence of a
death signal has been mapped to two regions of the mole-
cule: the NH
 
2
 
-terminal ART domain and the COOH-ter-
minal TM. Our results indicate a regulated mechanism by
which a death signal can cause translocation of BAX to
mitochondria where it mediates and amplifies membrane
dysfunction (reviewed in Reed, 1997; Hengartner, 1998).
 
Materials and Methods
 
Immunocytochemistry
 
FL5.12 cells were resuspended in fresh media containing 400 nM Mi-
totracker Green FM (Molecular Probes, Inc., Eugene, OR). After a 15-
min incubation, cells were washed and fixed in 3% paraformaldehyde and
blocked with 2% normal goat serum (Vector Labs, Inc., Burlingame, CA).
Anti-mBAX (P-19) Ab (Santa Cruz Biotechnology, Santa Cruz, CA) and
Cy3 goat anti–rabbit Ab (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA) were used to detect BAX immunoreactivity. Nuclei
were counterstained with Hoechst H33258 (1 
 
m
 
g/ml). Slides were viewed
and photographed with a Zeiss Axioskop fluorescence microscope and an
MC 100 camera attachment. Confocal laser scanning was performed using
a Sarastro 2000 confocal laser scanning microscope (Molecular Dynamics,
Inc., Sunnyvale, CA) and Image Space software (Molecular Dynamics).
 
Plasmids
 
Using standard recombinant DNA manipulations, cDNA encoding mu-
rine
 
 
 
BAX
 
D
 
1-19 was constructed in pBluescript SK under control of the T7
promoter; the resulting translation product had an initiating methionine
located 20 amino acids downstream of the original methionine of the full-
length BAX construct. cDNA encoding DHFR-BAX™ was created by
PCR in Bluescript SK, and encoded murine dihydrofolate reductase fused
to the COOH-terminal 23 amino acids (aa 169–192) of BAX. Similarly,
BAX-BCL-2™ was created by fusing amino acids 1–168 of BAX to amino
acid 218–239 of human BCL-2.
 
Mitochondria from Rat Heart
 
The heart of one male Sprague Dawley rat (
 
z
 
250 g) was placed in 
 
z
 
100
ml HIM buffer (0.2% wt/vol BSA, 200 mM mannitol, 70 mM sucrose, 10
mM Hepes-KOH, 1 mM EGTA, pH 7.5) on ice, squeezed several times to
force out blood, and transferred to 7.5 ml HIM in a 15-ml corex tube. All
subsequent steps were conducted at 4
 
8
 
C. The heart was homogenized with
a Polytron homogenizer (Brinkmann Instruments Canada Ltd., Missis-
sauga, ON, Canada) operating for 1 s at setting of 6.5. Nuclei and unbro-
ken cells were pelleted at 1,800 rpm for 10 min in a Sorvall SS34 rotor. The
supernatant was centrifuged for 10 min at 7,000 rpm. The resulting pellet
was resuspended in HIM (minus BSA), centrifuged at 1,800 rpm, and the
mitochondria were collected at 7,000 rpm. The mitochondrial pellet was
resuspended in cMRM (250 mM sucrose, 10 mM Hepes-KOH, 1 mM
ATP, 5 mM Na succinate, 0.08 mM ADP, 2 mM K
 
2
 
HPO
 
4
 
, pH 7.5) at a
concentration of 1 mg of mitochondrial protein per ml, and adjusted to 1
mM dithiothreitol just before use.
 
Mitochondria from Cultured Cells
 
Cells were collected, washed twice with PBS, suspended in 2 ml HIM, and
subjected to Polytron homogenization for four bursts of 10 s each at a set-
ting of 6.5. Mitochondria were then isolated according to the rat heart pro-
tocol.
 
Mitoplasts
 
Protein import-competent mitoplasts (mitochondria with a severely dis-
rupted outer membrane) in which the inner membrane and transbilayer
electrochemical potential remain intact were prepared from rat liver ex-
actly as described in McBride et al. (1995).
 
Mitochondrial Protein Targeting In Vitro
 
cDNAs were transcribed and translated in the presence of 
 
35
 
S-methionine
in a cell-free rabbit reticulocyte lysate system (Promega Corp., Madison,
WI) according to the manufacturer’s directions. For a standard mitochon-
drial protein import reaction, 5 
 
m
 
l of translation reaction was incubated
with 20 
 
m
 
l of Buffer A (20 mM Hepes-KOH, 10 mM KCl, 2.5 mM MgCl
 
2
 
,
1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, pH 7.5) and 25 
 
m
 
l mito-
chondria or mitoplasts in cMRM (1 mg protein/ml) at 30
 
8
 
C or 37
 
8
 
C for 30
min to 2 h. The import reaction was then layered on a 500-
 
m
 
l cushion of
1
 
3
 
 MRM (250 mM sucrose, 10 mM Hepes-KOH, pH 7.5) and centrifuged
for 4 min at top speed in a microfuge at 4
 
8
 
C. For alkali extraction, the mi-
tochondrial pellet was resuspended (0.25 mg protein/ml) in freshly pre-
pared 0.1 M Na
 
2
 
CO
 
3
 
, pH 11.5, and incubated for 30 min on ice. The mem-
branes were then pelleted in an airfuge (Beckman Instruments Canada,
Inc., Montreal, PQ, Canada) operating for 10 min at 30 psi. The pellet was
analyzed by SDS-PAGE and fluorography. For import assays that in-
cluded apoptotic cell extract (see below), it replaced buffer A; the buffer
used to make the extract, buffer A/ext, did not influence import.
 
Apoptotic Cell Extract
 
Extract was prepared at 4
 
8
 
C
 
 
 
according to the procedure of Liu et al.
(1996) with some minor modifications. In brief, human KB epithelial cells
were harvested in PBS containing
 
 
 
1.3 mM Na citrate and 0.6
 
 
 
mM EDTA.
The cell pellet was washed in buffer A/ext
 
 
 
(50 mM Pipes, 50 mM KCl, 5
mM EGTA, 2 mM MgCl
 
2
 
, 1 mM dithiothreitol, 20 
 
m
 
M cytochalasin B, pH
7.4), and was then resuspended in an equal volume of buffer A/ext. The
cells were disrupted by five cycles of freeze-thaw interspersed by five
strokes with a Wheaton glass homogenizer fitted with a B pestle, and cen-
trifuged at 10
 
5
 
 
 
g
 
 for 1 h in a Beckman Ti75 rotor. The resulting superna-
tant contained 10 mg protein/ml. To deplete the supernatant of cyto-
chrome c (Liu et al., 1996), 40 
 
m
 
l of 2G8.B6 anti-cytochrome c antibody
(7.7 mg protein/ml) was first incubated with 100 
 
m
 
l of a 1:1 mixture of pro-
tein A and protein G Sepharose resuspended in 200 
 
m
 
l of PBS for 4 h at
4
 
8
 
C. For the control reaction, 40 
 
m
 
l of buffer A was substituted for the an-
tibody. The beads were collected, washed with buffer A, and then incu-
bated with 125 
 
m
 
l of KB cell extract for 18 h at 4
 
8
 
C. The beads were recov-
ered and the supernatant was collected.
 
PARP Cleavage
 
KB apoptotic cell extract (50–100 
 
m
 
g protein) was incubated with 1 mM
dATP in a final volume of 20 
 
m
 
l of buffer A at 30
 
8
 
C for 1 h, and 1 
 
m
 
l of 
 
35
 
S-
methionine–labeled PARP derived by transcription-translation in rabbit
reticulocyte lysate was added. After 15 min at 30
 
8
 
C, 5 
 
m
 
l of 5
 
3
 
 SDS sam-
ple buffer was added, and 12.5-
 
m
 
l aliquots of each reaction were analyzed
by SDS-PAGE and fluorography.
 
1. 
 
Abbreviations used in this paper
 
: HA, hemagglutinin epitope; PARP,
poly(ADP ribosyl) polymerase; TM, transmembrane segment. 
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Results
 
BAX Integrates into Mitochondrial Membrane after a 
Death Stimulus In Vivo
 
Immunocytochemical analysis of FL5.12 hematopoietic
cells revealed BAX in association with mitochondria, as
well as distributed throughout the cytoplasm and perinu-
clear region (Fig. 1). When analyzed by immunoblotting,
the mitochondrial fraction isolated from these cells re-
vealed the presence of BAX as well as BCL-2, cytochrome
c oxidase subunit iv, and cytochrome c (Fig. 2 
 
A
 
, lanes 
 
1
 
and 
 
2
 
). In contrast to BCL-2, which was resistant to extrac-
tion at alkaline pH as a result of its integration into the
membrane lipid bilayer (Nguyen et al., 1993; Nguyen et al.,
1994), the majority of BAX was liberated under the same
conditions (Fig. 2 
 
A
 
, lanes 
 
3
 
 and 
 
4
 
; Fig. 2 
 
C
 
, lanes 
 
1
 
 and 
 
5
 
),
indicative of a peripheral association with the organelle
(Fujiki et al., 1982). After induction of cell death upon
withdrawal of IL-3 (Hockenbery et al., 1990), however,
this situation was reversed and most of the BAX now ac-
quired resistance to alkaline extraction (Fig. 2 
 
A
 
, lanes
 
5
 
–
 
8
 
; Fig. 2 
 
C
 
, lanes 
 
3
 
 and 
 
7
 
). As expected, cytochrome c
was released in response to alkaline extraction, whereas
BCL-2 and cytochrome c oxidase subunit iv
 
 
 
were retained,
and these distributions were unaffected by the death
stimulus (Fig. 2 
 
A
 
). We conclude, therefore, that BAX
demonstrates a specific response to the death signal in
vivo, moving from a membrane-peripheral to a mem-
brane-integrated position.
Of note, integration of BAX into mitochondrial mem-
brane after IL-3 withdrawal was also accompanied by an
apparent change at the extreme NH
 
2
 
 terminus of the pro-
tein. In isolated mitochondria, this region of the BAX
molecule was now accessible to limited proteolysis by ex-
ogenous trypsin or proteinase K, as revealed by the loss of
immunoreactivity of the cleavage product to an antibody
(N20) directed against amino acids 11–30 of BAX (Fig. 2
 
B
 
). The remaining protease-resistant BAX fragment, on
the other hand, retained immunoreactivity to an antibody
(651) directed against amino acids 43–61.
Finally, BAX integration into mitochondrial membrane
in response to IL-3 withdrawal from FL5.12 cells for 12 h
was partly blocked by the wide spectrum caspase inhibitor,
zVAD-fmk. Whereas the inhibitor did not significantly in-
fluence recovery of total BAX associated with mito-
chondria (Fig. 2 
 
C
 
, lanes 
 
3
 
 and 
 
4
 
), it reduced the amount of
alkaline-resistant membrane-integrated BAX that was re-
covered with the organelle (Fig. 2 
 
C
 
, lanes 
 
7
 
 and 
 
8
 
). This
suggests that caspases, which are activated in response to
IL-3 withdrawal, stimulate mitochondrial membrane inte-
gration of BAX in vivo.
 
An Apoptotic Cell Extract Stimulates BAX Targeting
to Mitochondria In Vitro
 
To examine BAX targeting into mitochondria in vitro, we
used the 
 
35
 
S-labeled transcription-translation product of
 
BAX
 
 cDNA in rabbit reticulocyte lysate combined with
intact mitochondria isolated from rat heart. This is a well-
documented system that faithfully reflects in vivo import
of diverse mitochondrial proteins, including insertion of
integral proteins into the mitochondrial outer membrane
(Li and Shore, 1992; McBride et al., 1992). The various
BAX constructs that were used for these assays, and their
targeting competence in vitro, are summarized in Fig. 3.
Transcription-translation of 
 
BAX
 
 cDNA yielded full-
length protein, as well as a prominent product 
 
z
 
2 kD
smaller and apparently arising from an internal translation
initiation, resulting in an NH
 
2
 
-terminal truncated BAX
(designated BAX
 
D
 
ART). However, only the truncated
BAX
 
D
 
ART was membrane-integrated, as judged by ac-
quired resistance to extraction at alkaline pH (Fig. 4 
 
A
 
;
compare lanes 
 
2
 
 and 
 
5
 
). Insertion of this product was tem-
perature-sensitive; it occurred at 30
 
8
 
C, but not at 4
 
8
 
C (Fig.
5, lanes 
 
2
 
–
 
5
 
), indicative of membrane integration rather
than tight but nonspecific binding (McBride et al., 1992).
Inspection of the BAX sequence revealed the presence
of an internal methionine at codon position 20 (Fig. 3).
Enforced translation initiation from met codon 20 was
achieved by deleting codon 1, which yielded a product that
comigrated in SDS PAGE with BAX
 
D
 
ART and demon-
strated temperature-sensitive membrane integration (Fig.
4 
 
B
 
). We conclude, therefore, that amino acids 1–19 of
full-length BAX harbors a domain, designated ART, that
is required for retention of BAX in a membrane insertion–
incompetent state. This domain is rich in glycine and hy-
droxylated amino acid residues (Fig. 3).
Importantly, the inability of full-length BAX to target
Figure 1. Subcellular distribution of BAX. BAX immunoreactiv-
ity localizes to mitochondria, perinuclear membrane, and cytosol
in FL5.12 cells. Immunofluorescent confocal microscopy of
FL5.12 cells using rabbit anti-BAX (P-19) antibody and goat Cy3
anti-rabbit Ig antibody shows both punctate and diffuse cytoplas-
mic immunoreactivity (A). MitoTracker Green FM shows ex-
clusive punctate labeling (B). Dual exposure of BAX and Mito-
Tracker labeling reveals colocalization of BAX with mitochondria
(yellow) as well as nonmitochondrial BAX immunoreactivity
(red; C). Conventional fluorescence detection of anti-BAX (P-
19) immunoreactivity (Cy3) and Hoechst H33258 nuclear stain
shows red cytoplasmic BAX immunoreactivity, blue nuclear
Hoechst staining and pink perinuclear signal where the two reac-
tivities overlap (D). 
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mitochondria in vitro was overcome by supplementing the
import reaction mixture with an apoptotic cell extract
derived from KB epithelial cells. This extract was pre-
pared according to Liu et al. (1996), and involved cycles of
freeze/thaw and homogenization of cells in hypotonic me-
dium, causing swelling of mitochondria and consequent
release of cytochrome c as a result of a ruptured outer
membrane. The resulting high-speed cytosolic supernatant
contains endogenous procaspases whose activation can
be achieved by adding dATP and incubating the extract
at 37
 
8
 
C, resulting in diagnostic cleavage of the caspase-3
death substrate, poly(ADP ribosyl) polymerase (PARP;
Liu et al., 1996). The presence of this extract in import re-
actions stimulated binding (Fig. 4 A, lanes 3 and 4) and al-
kaline-resistant membrane insertion of full-length BAX
(lanes 6 and 7), but did not stimulate BAXDART inser-
tion (lanes 6 and 7). Membrane-integrated BAX was ac-
cessible to exogenous trypsin in these intact mitochondria
Figure 2. Mitochondrial BAX changes its alkali and protease sen-
sitivity after a death stimulus. (A) BAX becomes alkali-resistant
after a death stimulus. Heavy membranes enriched in mitochon-
dria were prepared from FL5.12 cells cultured in IL-3 (lanes 1–4)
or deprived of IL-3 for 12 h (lanes 5–8), incubated in isotonic
buffer (lanes 1 and 2 and lanes 5 and 6), or in 0.1 M Na2CO3, pH
11.5 (lanes 3 and 4 and lanes 7 and 8), and centrifuged at 200,000 g
for 45 min to yield supernatant (S) and pellet (P). The fractions
were analyzed by immunoblot for BAX, BCL-2, cytochrome c ox-
idase subunit iv, and cytochrome c. (B) The NH2-terminus of
BAX is further exposed after a death stimulus. The mitochondrial
fraction prepared from FL5.12 cells in IL-3 (lanes 1 and 2 and
lanes 6 and 7) or deprived of IL-3 for 12 h (lanes 3–5, and lanes
8–10) were incubated in isotonic buffer and treated with trypsin
(30 mg/ml; lanes 2, 4, and 5) or proteinase K (100 mg/ml; prot. K,
lanes 7, 9, and 10), for 20 min at 48C. Trypsin was inactivated by
adding a 30-fold weight excess of soybean trypsin inhibitor, and
proteinase K was inactivated with phenylmethylsulfonylfluoride
(1 mM). The fractions were analyzed by immunoblot with anti-
BAX 651 antibody (amino acids 43–61; lanes 1–4 and lanes 6–9)
or with anti-BAX N20 antibody (amino acids 11–30; Santa Cruz
Biotechnology; lanes 5 and 10). (C) zVAD-fmk reduces mito-
chondrial membrane integration of BAX after IL-3 withdrawal.
The mitochondrial fraction prepared from FL5.12 cells main-
tained in IL-3 (lanes 1, 2, 5, and 6) or deprived of IL-3 for 12 h
(lanes 3, 4, 7, and 8) in the absence (lanes 1, 3, 5, and 7) or pres-
ence (lanes 2, 4, 6, and 8) of 50 mM zVAD-fmk for 12 h, were an-
alyzed either directly (lanes 1–4) or after extraction with 0.1 M
Na2CO3, pH 11.5 (lanes 5–8), as described in A.Goping et al. BAX Targeting to Mitochondria 211
(not shown), indicative of insertion into the outer mem-
brane. Apoptotic activity of the cell extract was verified by
demonstrating its capacity to generate the 24-kD apop-
totic fragment of PARP in response to dATP (Liu et al.,
1996) (Fig. 4 C). Nonapoptotic high speed cytosol did not
stimulate import of BAX, and did not support cleavage of
PARP (not shown). Also, BAX failed to target mitoplasts
(mitochondria partially or wholly stripped of outer mem-
brane) in the absence of apoptotic extract (not shown), in-
dicating that failure to import cannot be explained by the
fact that an intact outer membrane constitutes a barrier
that prevents BAX from accessing the inner membrane.
Finally, pretreatment of intact mitochondria with trypsin
abolished subsequent membrane insertion of full-length
BAX in response to apoptotic extract (Fig. 4 D), indicat-
ing that insertion is dependent on protein(s) exposed on
the organelle surface.
ART and TM Domains Are Required for Regulated 
Targeting of BAX In Vitro
The results presented in Fig. 4 demonstrate that apoptotic
regulation of BAX targeting in vitro can be bypassed by
deleting the NH2-terminal ART domain, resulting in con-
stitutive targeting of the protein. Similarly, replacement of
the entire cytosolic portion of BAX (amino acids 1–168)
with that of the monomeric reporter protein dihydrofolate
reductase (DHFR-BAX™) permitted import into the outer
membrane of intact mitochondria in the absence of apop-
totic cell extract, as revealed by temperature-sensitive ac-
quisition of resistance to extraction at alkaline pH (Fig. 5,
lanes 6–10). This shows that the BAX TM can function as
a signal-anchor sequence that, in the appropriate context,
is independently active in targeting and membrane inser-
tion. It also suggests that ART directly or indirectly pre-
vents manifestation of this signal-anchor function of the
BAX TM in the context of the full-length BAX molecule.
Importantly, however, replacement of the COOH-termi-
nal 22 amino acids of full-length BAX, which contains the
TM, with the corresponding TM domain of BCL-2 now
permitted targeting of the previously membrane inser-
tion–incompetent BAX (Fig. 5, lanes 11–15). Thus, the
mechanism underlying the inability of BAX to target mi-
tochondria in vitro requires both the presence of the spe-
cific BAX TM within the molecule, as well as the NH2-ter-
minal ART domain.
BAXDART and BAX-BCL-2™ Exhibit
Enhanced Cytotoxicity
In cotransfection experiments with a luciferase reporter as
an index of survival of COS-7 and CHO cells (Ng et al.,
1997), expression of hemagglutinin epitope (HA)-BAX-
DART or HA-BAX-BCL-2™ resulted in luciferase activ-
ity three to five times lower than that obtained with
HA-BAX 24 h after transfection (not shown). Moreover,
when analyzed microscopically by immunofluorescence
with anti-HA antibody, 7.5% of cells expressed HA-BAX
at 24 h, whereas ,1% expressed HA-BAXDART weakly
(not shown), indicating that most cells expressing HA-BAX
DART had previously perished. Thus, the enhanced cyto-
toxicity of HA-BAXDART compared with HA-BAX in
vivo correlates with inhibition of BAX membrane integra-
tion by the ART domain in vitro.
Stimulation of BAX Targeting by Cell Extract Requires 
Cytochrome c and Is Inhibited by zVAD-fmk
When high-speed apoptotic cytosol supplemented with
dATP was examined for its ability to support targeting of
full-length BAX to mitochondria in vitro, a marked dose-
dependent stimulation was observed (Fig. 6 A). Of note,
no improvement to mitochondrial membrane insertion of
BAX was achieved by providing additional cytochrome c
(lanes 6–9). The requirement for nucleotide co-factor in
the apoptotic extract was not assessed because ATP,
which can substitute for dATP in caspase activation, is
normally required for mitochondrial protein import. De-
pleting cytochrome c from the high-speed cytosol by im-
munoadsorption before adding dATP and incubating at
378C (Fig. 6 B, left), on the other hand, inhibited the ability
of the extract to support BAX targeting (Fig. 6 B, middle,
compare lanes 4 and 6) and PARP cleavage (Fig. 6 B,
right, compare lanes 3 and 6); cytochrome c reinstated
both events when added back to the extract (Fig. 6 B mid-
dle and right; compare lanes 6 and 7). Also, at least one
other factor present in the extract was needed for cyto-
chrome c–dependent regulation of BAX targeting to mito-
chondria since supplementation of reticulocyte lysate
translation mixtures with cytochrome c alone failed to
stimulate BAX targeting (not shown). Consistent with this
and with the role of cytochrome c in initiating activation of
a caspase cascade (Li et al., 1997), the wide spectrum in-
hibitor of caspases, zVAD-fmk (Zhu et al., 1995), was
found to inhibit BAX targeting supported by apoptotic
Figure 3. BAX constructs and their competence for mitochon-
drial targeting in vitro. ART domain (gray box); TM (black box);
1, targeting-competent; 2, targeting-incompetent. Amino acids
1–20 of BAX from the indicated species are shown. See text for
additional details.The Journal of Cell Biology, Volume 143, 1998 212
high-speed cytosol effectively (Fig. 6 C, left; compare lanes
3 and 4) at concentrations that abolished the ability of the
extract to drive PARP cleavage (Fig. 6 C, right; compare
lanes 2 and 3).
Discussion
In vivo, BAX is restrained from inserting into target mem-
branes, including mitochondria, until the cell receives a
death signal. Similarly, BAX synthesized in a rabbit reticu-
locyte translation system fails to target mitochondria in
vitro. Failure to target in this reconstituted mitochondrial
import reaction depends on two regions within the BAX
polypeptide: the NH2-terminal ART domain and the
COOH-terminal TM. Significantly, the TM functions as a
signal anchor that is required for targeting and insertion
into the mitochondrial outer membrane. Under normal
conditions, however, manifestation of this signal-anchor
activity is repressed, and depends not only on the nature of
the signal-anchor itself but on the NH2-terminal ART do-
main as well. As expected, deletion of the ART domain
enhances the cytotoxic properties of BAX in vivo, which
correlates with stimulation of membrane integration in
vitro. Although the underlying mechanism for stimulating
BAX targeting remains to be elucidated, it is noteworthy
that overexpression of the protein in vivo induces cell
death (Xiang et al., 1996; Rossé et al., 1998). This is con-
sistent, for example, with the existence of a saturable in-
hibitor of BAX targeting. It is interesting in this regard
that the NH2 terminus, including the ART domain, is fur-
ther exposed after membrane insertion of BAX in vivo
(Fig. 2 B).
After delivery of diverse death signals to cells in culture
(Hsu et al., 1997; Wolter et al., 1997), BAX moves to mito-
chondria and other membrane sites, and triggers a cata-
strophic transformation of mitochondrial function. This
transformation includes release of cytochrome c to the
surrounding cytosol, production of reactive oxygen spe-
cies, loss of transmembrane potential, and induction of mi-
tochondrial permeability transition (Xiang et al., 1996;
Rossé et al., 1998), events that result in apoptotic cell
death (Reed, 1997; Kroemer, 1997). Of note, BCL-2 pro-
teins have the potential to intercede and block these
BAX-induced events at several levels, including preven-
tion of BAX redistribution after a death signal (Gross et
al., 1998), heterodimerization with mitochondrial BAX
Figure 4. Apoptotic cell ex-
tract supports BAX targeting
to mitochondria in vitro.
(A)  35S-labeled transcription-
translation products of BAX
cDNA in rabbit reticulocyte
lysate (BAX and BAX-
DART) were incubated with
purified intact mitochondria
from rat heart in a standard
protein import reaction sup-
plemented with 1 mM dATP
(lanes 3, 4, 6, and 7) or 1 mM
dATP and 200 mg apoptotic
cytosol protein (Extract;
lanes  4 and 7) in a volume of
50 ml. At the end of the reac-
tion, mitochondria were re-
covered by centrifugation,
and the pellets were analyzed
by SDS PAGE and fluorog-
raphy either directly or after
extraction with 0.1 M
Na2CO3, pH 11.5 (Alkali;
lanes 5–7). Lane 1, 10% of
input translation product.
(B) As in A except that im-
port was conducted with
BAXD1-19 cDNA transcrip-
tion product (lane 2) at 48C
or 308C as indicated, and was analyzed after extraction of the mitochondria with 0.1M Na2CO3, pH 11.5 (lanes 4 and 5). (C) 35S-labeled
transcription-translation product of PARP cDNA in reticulocyte lysate (5% by volume) was incubated with (lanes 2 and 3) or without
(lane 1) 100 mg apoptotic cytosol protein in a total volume of 20 ml, in the presence (lane 3) or absence (lanes 1 and 2) of 1 mM dATP,
and equivalent portions were analyzed for the appearance of the 24-kD cleavage product of PARP (24K PARP) by 12% SDS PAGE
and fluorography. (D) As in A, except that before import, mitochondria were treated with 0.4 mg/ml trypsin and 50-fold weight excess
soybean trypsin inhibitor added either at the beginning (2 Pre-Trypsin; columns 2 and 4) or at the end (1 Pre-Trypsin; columns 1 and 3)
of the reaction. Mitochondria were collected by centrifugation and import conducted in the presence (columns 3 and 4) or absence (col-
umns 1 and 2) of apoptotic cytosol (Extract), and the relative amount of alkali-insoluble full-length BAX was determined (maximum set
at 100).Goping et al. BAX Targeting to Mitochondria 213
(Oltvai et al., 1993), and inhibition of cytochrome c release
(Kluck et al., 1997; Yang et al., 1997), and interception of
cytochrome c–mediated downstream pathways (Li et al.,
1997; Rossé et al., 1998; Zhivotovsky et al., 1998; Pan et al.,
1998).
In view of the fact that zVAD-fmk partly blocked BAX
insertion into mitochondrial membrane in response to a
death signal in vivo (Fig. 2 C), we examined apoptotic cy-
tosolic extracts (Liu et al., 1996) with the potential to acti-
vate a caspase cascade, and its influence on BAX targeting
to mitochondria in vitro. Previous analyses of such an ex-
tract led to the discovery of a core caspase-activating com-
plex in mammalian cells in which cytochrome c and the
nucleotide cofactor dATP/ATP (Liu et al., 1996) interact
with the Ced-4 homologue Apaf-1 (Zou et al., 1997),
causing it to recruit and activate initiator procaspase-9.
Caspase-9, in turn, processes procaspase-3 (Li et al., 1997).
When such an extract was added in vitro to a reticulocyte
lysate harboring BAX, targeting and mitochondrial mem-
brane integration was stimulated. This stimulating activity
depended on cytochrome c being present in these extracts
during incubations to activate caspases, and was blocked
by the wide spectrum caspase inhibitor, zVAD-fmk. In
view of current models suggesting that BAX initiates cyto-
chrome c release from mitochondria (see Jürgensmeier et
al., 1998), however, these findings were unexpected. One
possibility, therefore, is that the in vitro reconstitution
sytem described here reflects a mechanism for amplifying
BAX targeting. In this scenario, BAX targeting to mito-
chondria might be initiated by a signal transduction event;
BAX, as a consequence of its pore-forming properties
(Schlesinger et al., 1997), then triggers release of cyto-
chrome c and activation of a caspase, which in turn cleaves
a protein that regulates BAX targeting (e.g., it inactivates
an inhibitor or activates an inducer of BAX targeting).
This model is consistent with the partial inhibitory influ-
ence of zVAD-fmk on stimulated membrane integration
of BAX in vivo.
Alternatively, release of low levels of cytochrome c
might be initiated by a BAX-independent event, perhaps
involving controlled swelling of mitochondria and local-
ized rupture of the outer membrane (Vander Heiden et
al., 1997). This release in turn would result in activation of
caspases, stimulation of BAX targeting, and consequent
amplification of cytochrome c release via a BAX-medi-
ated process. One consequence of the possibility that lim-
ited rupturing of the outer membrane may precede BAX
targeting to mitochondria relates to the options for final
destination of the protein. In this scenario, BAX might
gain access to and directly influence both the outer and in-
ner membranes. However, failure to access the inner
membrane does not explain the failure of BAX to target
mitochondria in the absence of a death signal, since mito-
plasts do not insert BAX in the absence of apoptotic cyto-
sol (not shown).
In conclusion, we have found that activation of one or
more zVAD-sensitive caspases stimulate BAX targeting
to mitochondria, possibly by influencing, directly or indi-
rectly the activity of a regulator that controls membrane
insertion of BAX. Regulated targeting of BAX depends
on both the NH2-terminal ART domain and the COOH-
terminal TM within the BAX molecule. It remains to be
Figure 5. Failure of BAX to
target mitochondria in vitro
depends on the BAX TM.
cDNAs encoding BAX (lanes
2–5), cytosolic dihydrofolate
reductase fused at its COOH
terminus to amino acids 169–
192 of BAX (DHFR-BAX™,
lanes  7–10), and BAX in
which the COOH-terminal
24 amino acids have been re-
placed by the corresponding
domain of BCL-2 (amino ac-
ids 218–239) (BAX-BCL-
2™, lanes 12–15) were tran-
scribed and translated in
reticulocyte lysate and the
35S-labeled, alkali-insoluble
mitochondrial import prod-
ucts were analyzed by SDS
PAGE and fluorography.
Lanes  1, 6, and 11 represent
10% of input translation
product, as indicated. The
sequence (single letter code)
of the COOH-terminal 24
amino acids of BAX and 22
amino acids of BCL-2 are
shown; bold letters designate
the predicted TMs.The Journal of Cell Biology, Volume 143, 1998 214
determined, however, if these domains mediate physical
association of BAX with cytosolic or membrane proteins
that control targeting, or if they are susceptible to other
forms of regulation.
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